SARS-CoV-2-Omicron

Angelika Wagner1, Erika Garner-Spitzer1, Claudia Auer1

  • 1Institute of Specific Prophylaxis and Tropical Medicine, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, 1090 Vienna, Austria.

Vaccines
|May 25, 2024
PubMed
概括

多发性骨髓瘤患者对COVID-19疫苗的抗体反应不佳,即使在增强剂后也是如此. 疫苗接种和感染的混合免疫力改善了对没有严重疾病的变体的保护.